Skip to main content
. Author manuscript; available in PMC: 2008 Nov 22.
Published in final edited form as: Adv Drug Deliv Rev. 2008 Feb 8;60(8):886–898. doi: 10.1016/j.addr.2007.11.009

Fig. 1.

Fig. 1

Model for targetable polymer-drug conjugates according to Ringsdof [1], in which a solubility enhancer, a pharmacokinetic modifier, a homing device, and specific drugs or imaging probes could be attached to the same polymeric chain.